tiprankstipranks
Advertisement
Advertisement

SHTDF Stock Latest News

Sinopharm Accord’s First-Quarter Profit Drops as Revenue Slips and Cash Flow Weakens
Company AnnouncementsSinopharm Accord’s First-Quarter Profit Drops as Revenue Slips and Cash Flow Weakens
2d ago
Sinopharm posts unaudited Q1 2026 figures, highlighting RMB 400.8bn asset base
PremiumCompany Announcements
Sinopharm posts unaudited Q1 2026 figures, highlighting RMB 400.8bn asset base
4d ago
Sinopharm Medical Device Unit Sees Profit Decline Amid Modest Revenue Growth
PremiumCompany Announcements
Sinopharm Medical Device Unit Sees Profit Decline Amid Modest Revenue Growth
8d ago
Sinopharm subsidiary posts steady Q1 profit growth but cash flow weakens
PremiumCompany Announcements
Sinopharm subsidiary posts steady Q1 profit growth but cash flow weakens
9d ago
Sinopharm Accord Q1 2026 Preliminary Results Show Profit Decline Amid Stable Asset Base
PremiumCompany Announcements
Sinopharm Accord Q1 2026 Preliminary Results Show Profit Decline Amid Stable Asset Base
10d ago
Sinopharm Sets April Board Meeting to Approve First-Quarter 2026 Results
PremiumCompany AnnouncementsSinopharm Sets April Board Meeting to Approve First-Quarter 2026 Results
21d ago
Sinopharm Subsidiary Sinopharm Accord Posts Sharp 2025 Profit Rebound Despite Weaker Cash Flow
Premium
Company Announcements
Sinopharm Subsidiary Sinopharm Accord Posts Sharp 2025 Profit Rebound Despite Weaker Cash Flow
29d ago
Sinopharm Defies Industry Headwinds With 2025 Profit Growth and Retail Turnaround
Premium
Company Announcements
Sinopharm Defies Industry Headwinds With 2025 Profit Growth and Retail Turnaround
1M ago
Sinopharm Proposes Final Cash Dividend of RMB 0.69 per Share for 2025
PremiumCompany Announcements
Sinopharm Proposes Final Cash Dividend of RMB 0.69 per Share for 2025
1M ago
Sinopharm Subsidiary Posts 2025 Revenue Growth Amid Flat Earnings and Stronger Cash Flow
PremiumCompany Announcements
Sinopharm Subsidiary Posts 2025 Revenue Growth Amid Flat Earnings and Stronger Cash Flow
1M ago
Sinopharm Device Subsidiary Boosts Profit and Cash Flow Despite Lower 2025 Revenue
PremiumCompany Announcements
Sinopharm Device Subsidiary Boosts Profit and Cash Flow Despite Lower 2025 Revenue
1M ago
Sinopharm Accord Posts Strong 2025 Profit Growth Despite Slight Revenue Dip
PremiumCompany Announcements
Sinopharm Accord Posts Strong 2025 Profit Growth Despite Slight Revenue Dip
1M ago
Sinopharm Sets March Board Meeting to Approve 2025 Annual Results
PremiumCompany AnnouncementsSinopharm Sets March Board Meeting to Approve 2025 Annual Results
2M ago
Sinopharm Group Details Board Composition and Committee Roles
Premium
Company Announcements
Sinopharm Group Details Board Composition and Committee Roles
4M ago
Sinopharm Shareholders Approve New Board Appointments at Extraordinary Meeting
Premium
Company Announcements
Sinopharm Shareholders Approve New Board Appointments at Extraordinary Meeting
4M ago
Sinopharm Group Announces EGM to Appoint New Directors
PremiumCompany Announcements
Sinopharm Group Announces EGM to Appoint New Directors
5M ago
Sinopharm Group Announces Board Composition and Committee Roles
PremiumCompany Announcements
Sinopharm Group Announces Board Composition and Committee Roles
6M ago
Sinopharm Group Announces Executive Director Changes
PremiumCompany Announcements
Sinopharm Group Announces Executive Director Changes
6M ago
Sinopharm Group Reports Third Quarter 2025 Financial Results
PremiumCompany Announcements
Sinopharm Group Reports Third Quarter 2025 Financial Results
6M ago
Sinopharm Group Reports Mixed Nine-Month Financial Results
PremiumCompany AnnouncementsSinopharm Group Reports Mixed Nine-Month Financial Results
6M ago
Sinopharm Group Reports Strong Financial Position for Nine Months Ending September 2025
Premium
Company Announcements
Sinopharm Group Reports Strong Financial Position for Nine Months Ending September 2025
6M ago
Sinopharm’s CNMDC Reports Mixed Financial Results for 2025
Premium
Company Announcements
Sinopharm’s CNMDC Reports Mixed Financial Results for 2025
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >